Tentt

Vega Therapeutics Acquired by Incyte | Healthcare M&A Deal

Announced
HealthcareOther

Deal Overview

Incyte has acquired Vega Therapeutics, a healthcare services other business in Delaware, for $1.25 billion. Vega Therapeutics focuses on healthcare services other activities, supporting drug development and related therapeutic programs. Incyte acquisitions in healthcare M&A aim to expand capabilities and strengthen its pipeline execution through this strategic acquisition. The Incyte acquisitions deal is classified as an other acquisition and is structured as a strategic acquisition with an announced status and over $100M deal size.

Key Details

Transaction
Incyte acquires Vega Therapeutics
Deal Size
Over $100M
Reported Value
$1.25 billion

Filed under

Source

Read full article on businesswire.com

via GN - entered into definitive agreement · June 8, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →